Chemotherapeutic Agents That Induce Mitochondrial Apoptosis
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
577-590
Author(s):
Tadashi Asakura and Kiyoshi Ohkawa
Alphaviruses and their Derived Vectors as Anti-Tumor Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
597-607
Author(s):
Gregory J. Atkins, James W. P. Smyth, Marina N. Fleeton, Sareen E. Galbraith and Brian J. Sheahan
The Life Cycle of Cutaneous T Cell Lymphoma Reveals Opportunities for Targeted Drug Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
609-619
Author(s):
Carole L Berger and Richard Edelson
Ruthenium as an Effective Nitric Oxide Scavenger
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1585-1603
Author(s):
Celine J. Marmion, Beth Cameron, Clodagh Mulcahy and Simon P. Fricker
Iron Chelators in Cancer Chemotherapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1623-1635
Author(s):
Joan L. Buss, Bryan T. Greene, JoLyn Turner, Frank M. Torti and Suzy V. Torti
Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
175-184
Author(s):
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Medical Treatment of Peripheral Arterial Disease: Current Concepts and Future Options
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
211-218
Author(s):
Frank Schroder and Thomas Weiss
Lifestyle Changes and Pharmacological Risk Factor Modification for Effective Vascular Disease Prevention
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
219-223
Author(s):
Debabrata Mukherjee
Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
243-253
Author(s):
Irene Gazi, Evangelos Liberopoulos, Dimitri P. Mikhailidis and Moses Elisaf
Prostacyclin Synthase Gene: Implication and Prevention of Cardiovascular Disease
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
255-261
Author(s):
Tomohiro Nakayama